REFERENCES
1. Ma L, Li Y, Peng J, et al. Discovery of the migrasome, an organelle mediating release of cytoplasmic contents during cell migration. Cell Res. 2015;25:24-38.
2. Qian L, Chen P, Zhang S, et al. The uptake of extracellular vesicles: research progress in cancer drug resistance and beyond. Drug Resist Updat. 2025;79:101209.
3. Liang H, Ma X, Zhang Y, et al. The formation of migrasomes is initiated by the assembly of sphingomyelin synthase 2 foci at the leading edge of migrating cells. Nat Cell Biol. 2023;25:1173-84.
4. Ding T, Ji J, Zhang W, et al. The phosphatidylinositol (4,5)-bisphosphate-Rab35 axis regulates migrasome formation. Cell Res. 2023;33:617-27.
5. Zhu M, Zou Q, Huang R, et al. Lateral transfer of mRNA and protein by migrasomes modifies the recipient cells. Cell Res. 2021;31:237-40.
6. Zhang C, Li T, Yin S, et al. Monocytes deposit migrasomes to promote embryonic angiogenesis. Nat Cell Biol. 2022;24:1726-38.
7. Sun P, Li Y, Yu W, et al. Low-intensity pulsed ultrasound improves myocardial ischaemia‒reperfusion injury via migrasome-mediated mitocytosis. Clin Transl Med. 2024;14:e1749.
8. Hu M, Li T, Ma X, et al. Macrophage lineage cells-derived migrasomes activate complement-dependent blood-brain barrier damage in cerebral amyloid angiopathy mouse model. Nat Commun. 2023;14:3945.
9. Qin Y, Yang J, Liang C, et al. Pan-cancer analysis identifies migrasome-related genes as a potential immunotherapeutic target: a bulk omics research and single cell sequencing validation. Front Immunol. 2022;13:994828.
10. Gu C, Chen P, Tian H, et al. Targeting initial tumour-osteoclast spatiotemporal interaction to prevent bone metastasis. Nat Nanotechnol. 2024;19:1044-54.
11. Guo Z, Wen Y, He Q, et al. Migrasome and cancer - from cellular to clinical perspectives. Biomark Res. 2026;14:20.
12. Jeppesen DK, Fenix AM, Franklin JL, et al. Reassessment of exosome composition. Cell. 2019;177:428-45.e18.
13. Zhao X, Lei Y, Zheng J, et al. Identification of markers for migrasome detection. Cell Discov. 2019;5:27.
14. Huang Y, Zucker B, Zhang S, et al. Migrasome formation is mediated by assembly of micron-scale tetraspanin macrodomains. Nat Cell Biol. 2019;21:991-1002.
15. Chen YF, Luh F, Ho YS, Yen Y. Exosomes: a review of biologic function, diagnostic and targeted therapy applications, and clinical trials. J Biomed Sci. 2024;31:67.
16. Zhao Y, Tang S, Zhou J, Luo Y, Duan L. Migrasomes: a journey from biogenesis to multifaceted roles in health and disease. Biomark Res. 2026;14:31.
17. Liu B, Jiang Z, Song W, et al. PGC-derived migrasomes couple PGC proliferation with migration. Nat Commun. 2026;17:5022.
18. Deng Y, Zhang Y, Jia F, Jiang P, Li L, Huang Y. Targeting mitocytosis potentiates mitochondria drug delivery for antimetastasis therapy. Sci Adv. 2026;12:eaec7150.
19. Pant S, Hilton H, Burczynski ME. The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities. Biochem Pharmacol. 2012;83:1484-94.
20. Mehta MJ, Shin D, Park HS, et al. Exosome-based theranostic for gastrointestinal cancer: advances in biomarker discovery and therapeutic engineering. Small Methods. 2025;9:e2402058.
21. Zhang S, Liao X, Chen S, et al. Large oncosome-loaded VAPA promotes bone-tropic metastasis of hepatocellular carcinoma via formation of osteoclastic pre-metastatic niche. Adv Sci. 2022;9:e2201974.
22. Minciacchi VR, Freeman MR, Di Vizio D. Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes. Semin Cell Dev Biol. 2015;40:41-51.
23. Di Vizio D, Kim J, Hager MH, et al. Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. Cancer Res. 2009;69:5601-9.
24. Yang R, Zhang H, Chen S, et al. Quantification of urinary podocyte-derived migrasomes for the diagnosis of kidney disease. J Extracell Vesicles. 2024;13:e12460.
25. Zhang Y, Liu Y, Liu H, Tang WH. Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci. 2019;9:19.
26. Welsh JA, Goberdhan DCI, O’Driscoll L, et al.; MISEV Consortium. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles. 2024;13:e12404.
27. Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7:1535750.
28. Minciacchi VR, Spinelli C, Reis-Sobreiro M, et al. MYC mediates large oncosome-induced fibroblast reprogramming in prostate cancer. Cancer Res. 2017;77:2306-17.
29. Zhang R, Peng J, Zhang Y, et al. Pancreatic cancer cell-derived migrasomes promote cancer progression by fostering an immunosuppressive tumor microenvironment. Cancer Lett. 2024;605:217289.
30. Hu D, Li Z, Zheng B, et al. Cancer-associated fibroblasts in breast cancer: challenges and opportunities. Cancer Commun. 2022;42:401-34.
31. Qin S, Cao J, Ma X. Function and clinical application of exosome-how to improve tumor immunotherapy? Front Cell Dev Biol 2023;11:1228624.
33. Mohite P, Bogati R, Gorad A, Puri A, Singh S, Chittasupho C. Transforming cancer care with oncosomes: insight into biogenesis, functional role, and therapeutic potential. Pharmaceutics. 2026;18:207.
34. van den Bout I, Divecha N. PIP5K-driven PtdIns(4,5)P2 synthesis: regulation and cellular functions. J Cell Sci. 2009;122:3837-50.
35. Wu D, Xu Y, Ding T, Zu Y, Yang C, Yu L. Pairing of integrins with ECM proteins determines migrasome formation. Cell Res. 2017;27:1397-400.
36. Dharan R, Huang Y, Cheppali SK, et al. Tetraspanin 4 stabilizes membrane swellings and facilitates their maturation into migrasomes. Nat Commun. 2023;14:1037.
37. Zucker B, Dharan R, Wang D, Yu L, Sorkin R, Kozlov MM. Migrasome formation is initiated preferentially in tubular junctions by membrane tension. Biophys J. 2025;124:604-19.
38. Lu Z, Zuo S, Shi M, et al. Long-term intravital subcellular imaging with confocal scanning light-field microscopy. Nat Biotechnol. 2025;43:569-80.
39. Jiang D, Jiang Z, Lu D, et al. Migrasomes provide regional cues for organ morphogenesis during zebrafish gastrulation. Nat Cell Biol. 2019;21:966-77.
40. Lampiasi N, Russo R, Kireev I, Strelkova O, Zhironkina O, Zito F. Osteoclasts differentiation from murine RAW 264.7 cells stimulated by RANKL: timing and behavior. Biology. 2021;10:117.
41. Zhang X, Yao L, Meng Y, Li B, Yang Y, Gao F. Migrasome: a new functional extracellular vesicle. Cell Death Discov. 2023;9:381.
42. Jiao H, Jiang D, Hu X, et al. Mitocytosis, a migrasome-mediated mitochondrial quality-control process. Cell. 2021;184:2896-910.e13.
43. Jiang D, Jiao L, Li Q, et al. Neutrophil-derived migrasomes are an essential part of the coagulation system. Nat Cell Biol. 2024;26:1110-23.
44. Liu Y, Li S, Rong W, et al. Podocyte-released migrasomes in urine serve as an indicator for early podocyte injury. Kidney Dis. 2020;6:422-33.
46. Cui J, Zhang F, Jiang D, et al. An AIE-active near-infrared molecular probe for migrasome labeling. Biomaterials. 2025;319:123213.
47. Zhao W, Zhao S, Li L, et al. Sparse deconvolution improves the resolution of live-cell super-resolution fluorescence microscopy. Nat Biotechnol. 2022;40:606-17.
48. Huang X, Fan J, Li L, et al. Fast, long-term, super-resolution imaging with Hessian structured illumination microscopy. Nat Biotechnol. 2018;36:451-9.
49. Qian L, Chen P, Wang B, et al. CD147-positive migrasome macropinocytosis promotes HCC sorafenib resistance via inducing vasculogenic mimicry triggered by PI3K/AKT/TWIST1 signaling. Cell Death Dis. 2026;17:750.
50. Lee SY, Choi SH, Kim Y, et al. Migrasomal autophagosomes relieve endoplasmic reticulum stress in glioblastoma cells. BMC Biol. 2024;22:23.
51. Gu W, Zheng T, Li W, et al. Migrasomes derived from human umbilical cord mesenchymal stem cells: a new therapeutic agent for ovalbumin-induced asthma in mice. Stem Cell Res Ther. 2025;16:26.
52. Qian L, Fu Z, Chen P, et al. Lysophosphatidic acid-induced Arf6-driven macropinocytosis of CD147+ extracellular vesicles promotes sorafenib resistance of hepatocellular carcinoma. Int J Biol Sci. 2026;22:220-38.
53. Coffelt SB, Lewis CE, Naldini L, Brown JM, Ferrara N, De Palma M. Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors. Am J Pathol. 2010;176:1564-76.
54. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 2009;30:1073-81.
55. Coghlin C, Murray GI. Current and emerging concepts in tumour metastasis. J Pathol. 2010;222:1-15.
57. Jiang X, Wang J, Deng X, et al. The role of microenvironment in tumor angiogenesis. J Exp Clin Cancer Res. 2020;39:204.
58. Zhou Y, Yang D, Yang Q, et al. Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma. Nat Commun. 2020;11:6322.
59. DeNardo DG, Ruffell B. Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol. 2019;19:369-82.
60. Wang LJ, Xu R, Wu Y. Migrasome regulator TSPAN4 shapes the suppressive tumor immune microenvironment in pan-cancer. Front Immunol. 2024;15:1419420.
61. Boutilier AJ, Elsawa SF. Macrophage polarization states in the tumor microenvironment. Int J Mol Sci. 2021;22:6995.
62. Wu K, Lin K, Li X, et al. Redefining tumor-associated macrophage subpopulations and functions in the tumor microenvironment. Front Immunol. 2020;11:1731.
63. Li M, Wang M, Wen Y, Zhang H, Zhao GN, Gao Q. Signaling pathways in macrophages: molecular mechanisms and therapeutic targets. MedComm. 2023;4:e349.
64. Wang M, Xiong C, Mercurio AM. PD-LI promotes rear retraction during persistent cell migration by altering integrin β4 dynamics. J Cell Biol. 2022;221:e202108083.
67. Deniz IA, Karbanová J, Wobus M, et al. Mesenchymal stromal cell-associated migrasomes: a new source of chemoattractant for cells of hematopoietic origin. Cell Commun Signal. 2023;21:36.
68. Li G, Zhao Y, Wang H, et al. The M2 macrophages derived migrasomes from the surface of titania nanotubes array as a new concept for enhancing osteogenesis. Adv Healthc Mater. 2024;13:e2400257.
69. Li T, Su X, Lu P, et al. Bone marrow mesenchymal stem cell-derived dermcidin-containing migrasomes enhance LC3-associated phagocytosis of pulmonary macrophages and protect against post-stroke pneumonia. Adv Sci 2023;10:e2206432.
70. Liu Y, Zhang M, Wang C, et al. Human umbilical cord mesenchymal stromal cell-derived extracellular vesicles induce fetal wound healing features revealed by single-cell RNA sequencing. ACS Nano. 2024;18:13696-713.
71. Zhang K, Zhu Z, Jia R, et al. CD151-enriched migrasomes mediate hepatocellular carcinoma invasion by conditioning cancer cells and promoting angiogenesis. J Exp Clin Cancer Res. 2024;43:160.
72. Zhu Z, Zhang K, Wu W, et al. POSTN+ CAF-derived migrasomes drive hepatocellular carcinoma progression and confer resistance to immunotherapy. Research. 2025;8:0950.
73. Zhang Y, Wang J, Ding Y, et al. Migrasome and tetraspanins in vascular homeostasis: concept, present, and future. Front Cell Dev Biol. 2020;8:438.
74. Zeng MH, Qiu JG, Xu Y, Zhang XH. IDUA, NDST1, SAP30L, CRYBA4, and SI as novel prognostic signatures clear cell renal cell carcinoma. J Cell Physiol. 2019;234:16320-7.
75. Qi W, Sun L, Liu N, Zhao S, Lv J, Qiu W. Tetraspanin family identified as the central genes detected in gastric cancer using bioinformatics analysis. Mol Med Rep. 2018;18:3599-610.
76. Dong Y, Tang X, Zhao W, et al. TSPAN4 influences glioblastoma progression through regulating EGFR stability. iScience. 2024;27:110417.
77. Zhao WS, Yan WP, Chen DB, Dai L, Yang YB, et al. Genome-scale CRISPR activation screening identifies a role of ELAVL2-CDKN1A axis in paclitaxel resistance in esophageal squamous cell carcinoma. Am J Cancer Res. 2019;9:1183-200.
78. Kim SY, Johns SC, Gupta P, Varki N, Fuster MM. Targeting glycan sulfation in a CD11c+ myeloid population inhibits early KRAS-mutant lung neoplasia. Neoplasia. 2021;23:1137-43.
79. El Ghazal R, Yin X, Johns SC, et al. Glycan sulfation modulates dendritic cell biology and tumor growth. Neoplasia. 2016;18:294-306.
80. Fuster MM, Wang L, Castagnola J, et al. Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis. J Cell Biol. 2007;177:539-49.
81. Okolicsanyi RK, van Wijnen AJ, Cool SM, Stein GS, Griffiths LR, Haupt LM. Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicity. J Cell Biochem. 2014;115:967-76.
82. Qazi H, Shi ZD, Song JW, et al. Heparan sulfate proteoglycans mediate renal carcinoma metastasis. Int J Cancer. 2016;139:2791-801.
83. Yang C, Hu JF, Zhan Q, et al. SHCBP1 interacting with EOGT enhances O-GlcNAcylation of NOTCH1 and promotes the development of pancreatic cancer. Genomics. 2021;113:827-42.
84. Barua R, Mizuno K, Tashima Y, et al. Bioinformatics and functional analyses implicate potential roles for EOGT and L-fringe in pancreatic cancers. Molecules. 2021;26:882.
85. Shu Y, He L, Gao M, et al. EOGT correlated with immune infiltration: a candidate prognostic biomarker for hepatocellular carcinoma. Front Immunol. 2021;12:780509.
86. Zhang Y, Zhang M, Xie Z, et al. Research progress and direction of novel organelle-migrasomes. Cancers. 2022;15:134.
87. Okamura K, Hayashi M, Abe Y, Araki Y, Hozumi Y, Suzuki T. Microsatellite polymorphism located immediately upstream of the phosphatidylinositol glycan, class K gene (PIGK) affects its expression, which correlates with tyrosinase activity in human melanocytes. J Dermatol Sci. 2017;85:131-4.
88. Hu Q, Chen J, Liu Y, et al. TSPAN4+ fibroblasts coordinate metastatic niche assembly through migrasome-driven metabolic reprogramming and stromal-immune crosstalk in pancreatic adenocarcinoma. Front Immunol. 2025;16:1594879.
90. Rodolfo C, Campello S. Extracellular vesicles & Co.: scaring immune cells in the TME since ever. Front Immunol. 2024;15:1451003.
91. van Niel G, Carter DRF, Clayton A, Lambert DW, Raposo G, Vader P. Challenges and directions in studying cell-cell communication by extracellular vesicles. Nat Rev Mol Cell Biol. 2022;23:369-82.
92. Köktürk S, Doğan S, Yılmaz CE, Cetinkol Y, Mutlu O. Expression of brain-derived neurotrophic factor and formation of migrasome increases in the glioma cells induced by the adipokinetic hormone. Rev Assoc Med Bras. 2024;70:e20231337.
93. Zhang H, Cao K, Xiang J, Zhang M, Zhu M, Xi Q. Hypoxia induces immunosuppression, metastasis and drug resistance in pancreatic cancers. Cancer Lett. 2023;571:216345.
94. Wang S, Wu W, Lin X, et al. Predictive and prognostic biomarkers of bone metastasis in breast cancer: current status and future directions. Cell Biosci. 2023;13:224.
95. He DX, Gu XT, Li YR, Jiang L, Jin J, Ma X. Methylation-regulated miR-149 modulates chemoresistance by targeting GlcNAc N-deacetylase/N-sulfotransferase-1 in human breast cancer. FEBS J. 2014;281:4718-30.
96. Zhou Z, Yang Z, Zhou L, Yang M, He S. The versatile roles of testrapanins in cancer from intracellular signaling to cell-cell communication: cell membrane proteins without ligands. Cell Biosci. 2023;13:59.
97. Bianchini G, De Angelis C, Licata L, Gianni L. Treatment landscape of triple-negative breast cancer - expanded options, evolving needs. Nat Rev Clin Oncol. 2022;19:91-113.
98. Jiang Y, Liu X, Ye J, et al. Migrasomes, a new mode of intercellular communication. Cell Commun Signal. 2023;21:105.
99. Lawal B, Wu AT, Chen CH, T A G, Wu SY. Identification of INFG/STAT1/NOTCH3 as γ-Mangostin’s potential targets for overcoming doxorubicin resistance and reducing cancer-associated fibroblasts in triple-negative breast cancer. Biomed Pharmacother. 2023;163:114800.
100. Xu G, Li J. Recent advances in mass spectrometry imaging for multiomics application in neurology. J Comp Neurol. 2019;527:2158-69.
101. Yoshikawa K, Saito S, Kadonosono T, Tanaka M, Okochi M. Osmotic stress induces the formation of migrasome-like vesicles. FEBS Lett. 2024;598:437-45.
102. Maekawa K, Ri M, Nakajima M, et al. Serum lipidomics for exploring biomarkers of bortezomib therapy in patients with multiple myeloma. Cancer Sci. 2019;110:3267-74.
103. Zhang X, Liang Z, Wang S, et al. Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology. Cancer Biol Med. 2019;16:189-204.
104. Mohebali M, Kazemirad E, Hajjaran H, et al. Gene expression analysis of antimony resistance in Leishmania tropica using quantitative real-time PCR focused on genes involved in trypanothione metabolism and drug transport. Arch Dermatol Res. 2019;311:9-17.
105. Gupta B, Ramasamy T, Poudel BK, et al. Development of bioactive PEGylated nanostructured platforms for sequential delivery of doxorubicin and imatinib to overcome drug resistance in metastatic tumors. ACS Appl Mater Interfaces. 2017;9:9280-90.
106. Jiang Y, Lyu Z, Ralahy B, et al. Dendrimer nanosystems for adaptive tumor-assisted drug delivery via extracellular vesicle hijacking. Proc Natl Acad Sci U S A. 2023;120:e2215308120.
107. Dyshlovoy SA, Pelageev DN, Hauschild J, et al. Successful targeting of the Warburg effect in prostate cancer by glucose-conjugated 1,4-naphthoquinones. Cancers. 2019;11:1690.
108. Cai C, Shen J. The roles of migrasomes in immunity, barriers, and diseases. Acta Biomater. 2024;189:88-102.
109. Jiao L, Luo X, Xu Y, et al. Emerging concepts of migrasome: an up-and-coming organelle from biology to the clinic. FASEB J. 2024;38:e23811.
110. Yu L, Li J, Han Y, et al. O-GlcNAcylation of AMFR stabilizes TSPAN4 to regulate migrasome formation for viral release. Nat Commun. 2026;17:1506.
111. Jiang D, He J, Yu L. The migrasome, an organelle for cell-cell communication. Trends Cell Biol. 2025;35:205-16.
112. Zhang Y, Chen W, Zhu J, Xu L. The biogenesis and biological roles of migrasomes in human diseases. Cell Death Discov. 2025;11:296.
113. Chen QT, Huang QL, Han MZ, et al. ITM2B truncation promotes migrasome formation to accelerate renal cell carcinoma growth. Adv Sci. 2026;13:e11683.
114. Jiang MJ, Zhou HY, Bai YT, Chen XJ, Zhou G. Migrasome-transported PTGES amplifies the PGE2 cascade in SPP1+ macrophages to drive oral leukoplakia carcinogenesis. Nat Commun. 2026;17:4753.
